Form4insider filings, from the source

SEC Form 4 · accession 0000919574-18-002732

FENNEC PHARMACEUTICALS INC. · FENC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Aug 29, 2014
Accepted (ET)
Mar 29, 2018 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001211583

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Aug 29, 2014P1,666$2.46A1,809,844ISee Footnote
Common StockF3Aug 29, 2014P1,666$2.46A1,285,127D
Common StockF1,F2Oct 15, 2014P500$2.68A1,811,510ISee Footnote
Common StockF3Oct 15, 2014P500$2.68A1,285,627D
Common StockF1,F2Oct 15, 2014P300$2.69A1,811,810ISee Footnote
Common StockF3Oct 15, 2014P300$2.69A1,285,927D
Common StockF1,F2Nov 7, 2014P3,967$2.56A1,815,777ISee Footnote
Common StockF3Nov 7, 2014P3,967$2.56A1,289,894D
Common StockF1,F2Nov 10, 2014P600$2.72A1,816,377ISee Footnote
Common StockF3Nov 10, 2014P600$2.72A1,290,494D
Common StockF1,F2Dec 3, 2014P10,000$2.50A1,826,377ISee Footnote
Common StockF3Dec 3, 2014P10,000$2.50A1,300,494D
Common StockF1,F2Dec 4, 2014P300$2.76A1,826,677ISee Footnote
Common StockF3Dec 4, 2014P300$2.76A1,300,794D
Common StockF1,F2Dec 8, 2014P6,000$2.68A1,832,677ISee Footnote
Common StockF3Dec 8, 2014P6,000$2.68A1,306,794D
Common StockF1,F2Dec 10, 2014P2,000$2.50A1,834,677ISee Footnote
Common StockF3Dec 10, 2014P2,000$2.50A1,308,794D
Common StockF1,F2Dec 16, 2014P7,000$2.40A1,841,677ISee Footnote
Common StockF3Dec 16, 2014P7,000$2.40A1,315,794D
Common StockF1,F2Dec 18, 2014P5,500$2.34A1,847,177ISee Footnote
Common StockF3Dec 18, 2014P5,500$2.34A1,321,294D
Common StockF1,F2Dec 19, 2014P500$2.53A1,847,677ISee Footnote
Common StockF3Dec 19, 2014P500$2.53A1,321,794D
Common StockF1,F2Dec 22, 2014P2,500$2.23A1,850,177ISee Footnote
Common StockF3Dec 22, 2014P2,500$2.23A1,324,294D
Common StockF1,F2Dec 23, 2014P500$2.23A1,850,677ISee Footnote
Common StockF3Dec 23, 2014P500$2.23A1,324,794D
Common StockF4holding———192,666D
Common StockF5holding———166,666D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

(+) This is the first part of a Form 4 filing for the reporting persons. There are four parts to this Form 4 filing because of the constraint of a 30 transaction line maximum for tables in a Form 4.